FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer

Familial Nonmedullary Thyroid Carcinoma (FNMTC) makes up to 5–10% of all thyroid cancers, also including those FNMTC occurring as a minor component of familial cancer syndromes, such as Familial Adenomatous Polyposis (FAP). We give evidence that this extracolonic manifestation of FAP is determined by the same germline mutation of the APC gene responsible for colonic polyps and cancer but also shows some unusual features (F : M ratio = 80 : 1, absence of LOH for APC in the thyroid tumoral tissue, and indolent biological behaviour, despite frequent multicentricity and lymph nodal involvement), suggesting that the APC gene confers only a generic susceptibility to thyroid cancer, but perhaps other factors, namely, modifier genes, sex-related factors, or environmental factors, are also required for its phenotypic expression. This great variability is against the possibility of classifying all FNMTC as a single entity, not only with a unique or prevalent causative genetic factor, but also with a unique or common biological behavior and a commonly dismal prognosis. A new paradigm is also suggested that could be useful (1) for a proper classification of FAP associated PTC within the larger group of FNMTC and (2) for making inferences to sporadic carcinogenesis, based on the lesson from FAP.

[1]  T. Hadjistilianou,et al.  Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism , 2015, European Journal of Human Genetics.

[2]  K. Dahan,et al.  Evidence of digenic inheritance in Alport syndrome , 2015, Journal of Medical Genetics.

[3]  P. Parrilla,et al.  Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings. , 2014, Biochimica et biophysica acta.

[4]  J. Guillem,et al.  Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients. , 2014, American journal of surgery.

[5]  T. Dragani,et al.  Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients. , 2014, Lung cancer.

[6]  J. Guillem,et al.  The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. , 2012, Clinical colorectal cancer.

[7]  F. Cetta,et al.  Familial Adenomatous Polyposis-Associated Papillary Thyroid Carcinoma Shows an Indolent Course and Usually, but Not Always, Belongs to the Cribriform-Morular Variant of Papillary Thyroid Carcinoma , 2012, Acta Cytologica.

[8]  G. Ugolini,et al.  FAP associated cribriform morular variant of PTC: striking female prevalence and indolent course. , 2011, Endocrine journal.

[9]  J. Church,et al.  Screening for Thyroid Cancer in Patients With Familial Adenomatous Polyposis , 2011, Annals of surgery.

[10]  F. Cetta,et al.  Comment on “Extra-Intestinal Manifestations of Familial Adenomatous Polyposis” , 2009, Annals of Surgical Oncology.

[11]  F. Pacini,et al.  Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. , 2008, Endocrine-related cancer.

[12]  L. Sobrinho,et al.  Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. , 2008, The Journal of clinical endocrinology and metabolism.

[13]  F. Cetta,et al.  Inherited multitumoral syndromes including colorectal carcinoma. , 2007, Surgical oncology.

[14]  F. Cetta,et al.  Germ-line and Somatic Mutations of the APC Gene and/or ß Catenin Gene in the Occurrence of FAP Associated Thyroid Carcinoma , 2007, World Journal of Surgery.

[15]  D. Chung,et al.  Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  I. Bagwan,et al.  Cribriform-morular variant of papillary carcinoma: The sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma , 2006 .

[17]  R. Mariani-Costantini,et al.  Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli , 2005, Human mutation.

[18]  L. Thompson,et al.  Papillary Thyroid Carcinoma , 2004, Ear, nose, & throat journal.

[19]  A. Miyauchi,et al.  Cribriform-morular variant of Papillary Thyroid Carcinoma: Clue to Early Detection of Familial Adenomatous Polyposis-associated Colon Cancer , 2004, World Journal of Surgery.

[20]  G Riccabona,et al.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer , 2004, Journal of Medical Genetics.

[21]  M. Brandi,et al.  Papillary thyroid carcinoma. , 2003, The American journal of surgical pathology.

[22]  D. D. de Kretser,et al.  Cribriform‐morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis‐associated thyroid carcinoma. A case report with clinical and molecular genetic correlation , 2003, Pathology.

[23]  T. Sano,et al.  Cribriform‐morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the β‐catenin gene , 2003, The Journal of pathology.

[24]  M. Pelizzo,et al.  Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. , 1999, The American journal of pathology.

[25]  J. Chan,et al.  Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  N. Raffaelli,et al.  The relationships between phenotypic expression in patients with familial adenomatous polyposis (FAP) and the site of mutations in the adenomatous polyposis coli (APC) gene. , 1999, Annals of surgery.

[27]  A. Fusco,et al.  Genetic Alterations in Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Clinical Implications and Suggestions for Early Detection , 1998, World Journal of Surgery.

[28]  H. Gharib,et al.  Thyroid Cancer in Patients with Familial Adenomatous Polyposis , 1998, World Journal of Surgery.

[29]  G. Chiappetta,et al.  The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  F. Cetta Familial nonmedullary thyroid carcinomas: a heterogeneous syndrome with different natural history and variable long-term prognosis. , 1997, The Journal of clinical endocrinology and metabolism.

[31]  H. Harach Age, sex and C cells: what about the human thyroid follicle with acid mucin and solid cell nests? , 1997, Journal of Clinical Endocrinology and Metabolism.

[32]  P. Toti,et al.  Thyroid carcinoma associated with familial adenomatous polyposis , 1997, Histopathology.

[33]  F. Cetta,et al.  Thyroid cancer and the Chernobyl accident. Are long-term and long distance side effects of fall-out radiation greater than estimated? , 1997, The Journal of clinical endocrinology and metabolism.

[34]  J. Burgess,et al.  Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. , 1997, The Journal of clinical endocrinology and metabolism.

[35]  G. Williams,et al.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm , 1994, Histopathology.

[36]  H. Bussey,et al.  Adenomatous polyposis: An association with carcinoma of the thyroid , 1987, The British journal of surgery.

[37]  R. Stephenson A and V , 1962, The British journal of ophthalmology.

[38]  G. Ugolini,et al.  Screening for thyroid cancer in patients with familial adenomatous polyposis. , 2015, Annals of Surgery.

[39]  W. Marsden I and J , 2012 .

[40]  G. Chiappetta,et al.  The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. , 2002, The Journal of clinical endocrinology and metabolism.

[41]  P. Battista,et al.  Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene. , 2001, The Journal of clinical endocrinology and metabolism.

[42]  S. Olschwang,et al.  Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. , 2000, The Journal of clinical endocrinology and metabolism.

[43]  Z. Cohen,et al.  Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. , 1999, The American journal of pathology.

[44]  D. Williams Thyroid cancer and the Chernobyl accident. , 1996, The Journal of clinical endocrinology and metabolism.